Murray A Goldberg - Net Worth and Insider Trading
Murray A Goldberg Net Worth
The estimated net worth of Murray A Goldberg is at least $57 Million dollars as of 2024-11-13. Murray A Goldberg is the SVP Administration & Asst Secr of Regeneron Pharmaceuticals Inc and owns about 69,502 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $57 Million. Details can be seen in Murray A Goldberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Murray A Goldberg has not made any transactions after 2014-10-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Murray A Goldberg
Murray A Goldberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Murray A Goldberg owns 5 companies in total, including Aerie Pharmaceuticals Inc (AERI) , Ayala Pharmaceuticals Inc (ADXS) , and Teva Pharmaceutical Industries Ltd (TEVA) among others .
Click here to see the complete history of Murray A Goldberg’s form 4 insider trades.
Insider Ownership Summary of Murray A Goldberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AERI | Aerie Pharmaceuticals Inc | 2013-10-25 | director |
| ADXS | Ayala Pharmaceuticals Inc | 2020-05-07 | director |
| TEVA | Teva Pharmaceutical Industries Ltd | 2018-01-01 | director |
 | | 2014-10-24 | SVP Fin & Admin & CFO & & Treas |
| | 2023-01-19 | director |
Murray A Goldberg Latest Holdings Summary
Murray A Goldberg currently owns a total of 1 stock. Murray A Goldberg owns 69,502 shares of Regeneron Pharmaceuticals Inc (REGN) as of October 24, 2014, with a value of $57 Million.
Latest Holdings of Murray A Goldberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2014-10-24 | 69,502 | 821.00 | 57,061,142 |
Holding Weightings of Murray A Goldberg
Murray A Goldberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Murray A Goldberg has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 26,788 shares on October 24, 2014, which brought Murray A Goldberg around $11 Million.
Insider Trading History of Murray A Goldberg
- 1
Murray A Goldberg Trading Performance
Murray A Goldberg Ownership Network
Ownership Network List of Murray A Goldberg
Ownership Network Relation of Murray A Goldberg
Murray A Goldberg Owned Company Details
What does Aerie Pharmaceuticals Inc do?
Who are the key executives at Aerie Pharmaceuticals Inc?
Murray A Goldberg is the director of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .
Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerie Pharmaceuticals Inc Insider Transactions
Murray A Goldberg Mailing Address
Above is the net worth, insider trading, and ownership report for Murray A Goldberg. You might contact Murray A Goldberg via mailing address: 2030 Main Street, Suite 1500, Irvine Ca 92614.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
